Takeda's first-in-class narcolepsy drug claims FDA approval
Takeda's orexin agonist Orzeyful is the first drug approved in the US that can treat the "full range" of narcolepsy type 1 symptoms, says the FDA.
Newsletters and Deep Dive digital magazine
Takeda's orexin agonist Orzeyful is the first drug approved in the US that can treat the "full range" of narcolepsy type 1 symptoms, says the FDA.
CDC has a permanent director in place at last, after the Senate confirmed Erica Schwartz's nomination to what has become a politically charged role.
After a series of regulatory twists and turns, the FDA has approved Moderna's mRNA-based influenza vaccine mFlusiva.
Publication of the 2026 Pharma Package by the Council of the EU represents the most significant reform of EU pharmaceutical legislation in over 20 yrs
Patients in England with rare disease cystinosis will soon be able to access a drug that has been available in other UK nations for up to three years
Editor's Picks
Newsletters and Deep Dive
digital magazine
Editor's Picks